Defeng Pan (Yue Hu)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Acute Myocardial Infarction

Prognostic Factors

Percutaneous Coronary Intervention

Top Venues

Cardiovascular therapeutics

International urology and nephrology

This page only lists publications with an associated author ORCID identifier.

Publications

Defeng Pan, Xiaotong Wang, Shengjue Xiao, Chunyan Huan, Huimin Wu, Tao Xu, Minjia Guo, Defeng Pan, Defeng Pan
Development and Validation of a Nomogram Model for Predicting the Risk of Readmission in Patients with Heart Failure with Reduced Ejection Fraction within 1 Year. Cardiovascular therapeutics 2022 (2022)
Yue Hu, Xiaotong Wang, Shengjue Xiao, Huimin Wu, Chunyan Huan, Tao Xu, Minjia Guo, Ailin Liu, Xiaoyao Jiang, Jia Wang, Hong Zhu, Defeng Pan
Development and validation of a risk nomogram model for predicting pulmonary hypertension in patients with stage 3-5 chronic kidney disease. International urology and nephrology (2022)
Defeng Pan, Xiaotong Wang, Shengjue Xiao, Na Sun, Chunyan Huan, Huimin Wu, Minjia Guo, Tao Xu, Defeng Pan
A Clinical Nomogram Based on the Triglyceride-Glucose Index to Predict Contrast-Induced Acute Kidney Injury after Percutaneous Intervention in Patients with Acute Coronary Syndrome with Diabetes Mellitus. Cardiovascular therapeutics 2022 (2022)
Shengjue Xiao, Tongneng Xue, Qinyuan Pan, Defeng Pan, Qi Wu, Qiaozhi Liu, Xiaotong Wang, Ailin Liu, Jie Liu, Defeng Pan, Yufei Zhou, Defeng Pan
MicroRNA-146a Serves as a Biomarker for Adverse Prognosis of ST-Segment Elevation Myocardial Infarction. Cardiovascular therapeutics 2021 (2021)
Defeng Pan, Shengjue Xiao, Defeng Pan, Qinyuan Pan, Qi Wu, Xiaotong Wang, Qiaozhi Liu, Ailin Liu, Jie Liu, Defeng Pan, Yufei Zhou
Clinical Nomogram to Predict Major Adverse Cardiac Events in Acute Myocardial Infarction Patients within 1 Year of Percutaneous Coronary Intervention. Cardiovascular therapeutics 2021 (2021)